BBV STI surveillance and research programme: surveillance for hepatitis B indicators

A key aspect of Australia’s National Hepatitis B Strategy is the identification of specific measurable aims and targets, including increasing the proportion of people living with chronic hepatitis B (CHB) who have been diagnosed, increasing treatment uptake in those affected, and reducing the burden of attributable morbidity and mortality associated with the disease. The Surveillance for Hepatitis B Indicators project tracks progress towards these targets.

This project is led by the WHO Collaborating Centre for Viral Hepatitis.

Proposed tasks include:

1. Number of people living with chronic hepatitis B in Australia
2. Proportion of people living with chronic hepatitis B in Australia who have been diagnosed
3. Proportion of people living with chronic hepatitis B who are dispensed drugs for the treatment of hepatitis B through the Pharmaceutical Benefits Scheme
4. Burden of disease attributable to chronic hepatitis B in Australia

Indicator data estimate outputs will be incorporated into The Kirby Institute Annual Surveillance Report and the National Viral Hepatitis Mapping Project Reports, along with supporting interpretive and methodological information.

Surveillance for CHB indicators dashboard

Health Surveillance Fund, Australian Government Department of Health